Funding for this research was provided by:
Tri-Service General Hospital (848016012)
Received: 1 October 2021
Accepted: 15 December 2021
First Online: 10 January 2022
: The study protocol has been approved by the Medical Research Ethics Committee of Zuyderland Medical (METC number: METCZ20180091). All participants give written informed consent before any data is collected. The risks for participants are negligible and the burden can be considered minimal as the study will only create clinical recommendations towards the general practitioner or pharmacist, who will decide whether these recommendations are being followed or not. All the clinical recommendations rely on up-to-date guidelines.
: Not applicable.
: The authors declare that they have no competing interests.